Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Selective serotonin reuptake inhibitor use and risk of gestational hypertension.

Toh S, Mitchell AA, Louik C, Werler MM, Chambers CD, Hernández-Díaz S.

Am J Psychiatry. 2009 Mar;166(3):320-8. doi: 10.1176/appi.ajp.2008.08060817.

2.

Elevated risk of preeclampsia in pregnant women with depression: depression or antidepressants?

Palmsten K, Setoguchi S, Margulis AV, Patrick AR, Hernández-Díaz S.

Am J Epidemiol. 2012 May 15;175(10):988-97. doi: 10.1093/aje/kwr394.

3.

Antidepressant use during pregnancy and the risk of preterm delivery and fetal growth restriction.

Toh S, Mitchell AA, Louik C, Werler MM, Chambers CD, Hernández-Díaz S.

J Clin Psychopharmacol. 2009 Dec;29(6):555-60. doi: 10.1097/JCP.0b013e3181bf344c.

4.

Risks associated with selective serotonin reuptake inhibitors in pregnancy.

Malm H, Klaukka T, Neuvonen PJ.

Obstet Gynecol. 2005 Dec;106(6):1289-96.

PMID:
16319254
5.

Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors.

Grzeskowiak LE, Gilbert AL, Morrison JL.

J Clin Psychopharmacol. 2012 Oct;32(5):615-21. doi: 10.1097/JCP.0b013e31826686bc.

PMID:
22926594
6.

Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries.

Kieler H, Artama M, Engeland A, Ericsson O, Furu K, Gissler M, Nielsen RB, Nørgaard M, Stephansson O, Valdimarsdottir U, Zoega H, Haglund B.

BMJ. 2012 Jan 12;344:d8012. doi: 10.1136/bmj.d8012.

7.

Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.

Bakker MK, Kölling P, van den Berg PB, de Walle HE, de Jong van den Berg LT.

Br J Clin Pharmacol. 2008 Apr;65(4):600-6.

8.

Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.

El Marroun H, Jaddoe VW, Hudziak JJ, Roza SJ, Steegers EA, Hofman A, Verhulst FC, White TJ, Stricker BH, Tiemeier H.

Arch Gen Psychiatry. 2012 Jul;69(7):706-14. doi: 10.1001/archgenpsychiatry.2011.2333.

PMID:
22393202
9.

Effects of smoking and preeclampsia on birth weight for gestational age.

Spracklen CN, Ryckman KK, Harland K, Saftlas AF.

J Matern Fetal Neonatal Med. 2015 Apr;28(6):679-84. doi: 10.3109/14767058.2014.928853.

10.

Normal and high-normal blood pressures, but not body mass index, are risk factors for the subsequent occurrence of both preeclampsia and gestational hypertension: a retrospective cohort study.

Ohkuchi A, Iwasaki R, Suzuki H, Hirashima C, Takahashi K, Usui R, Matsubara S, Minakami H, Suzuki M.

Hypertens Res. 2006 Mar;29(3):161-7.

PMID:
16755151
11.

Antidepressant use and risk for preeclampsia.

Palmsten K, Huybrechts KF, Michels KB, Williams PL, Mogun H, Setoguchi S, Hernández-Díaz S.

Epidemiology. 2013 Sep;24(5):682-91. doi: 10.1097/EDE.0b013e31829e0aaa.

12.

Exposure to selective serotonin reuptake inhibitors in early pregnancy and the risk of miscarriage.

Andersen JT, Andersen NL, Horwitz H, Poulsen HE, Jimenez-Solem E.

Obstet Gynecol. 2014 Oct;124(4):655-61. doi: 10.1097/AOG.0000000000000447.

PMID:
25198261
13.

Does fetal exposure to SSRIs or maternal depression impact infant growth?

Wisner KL, Bogen DL, Sit D, McShea M, Hughes C, Rizzo D, Confer A, Luther J, Eng H, Wisniewski SW.

Am J Psychiatry. 2013 May;170(5):485-93. doi: 10.1176/appi.ajp.2012.11121873. Erratum in: Am J Psychiatry. 2013 Oct 1;70(10):1218.

14.

Risk of gestational hypertension in relation to folic acid supplementation during pregnancy.

Hernández-Díaz S, Werler MM, Louik C, Mitchell AA.

Am J Epidemiol. 2002 Nov 1;156(9):806-12.

15.
16.

First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.

Louik C, Lin AE, Werler MM, Hernández-Díaz S, Mitchell AA.

N Engl J Med. 2007 Jun 28;356(26):2675-83. Erratum in: N Engl J Med. 2015 Aug 13;373(7):686.

17.

Descriptive epidemiology of chronic hypertension, gestational hypertension, and preeclampsia in New York State, 1995-2004.

Savitz DA, Danilack VA, Engel SM, Elston B, Lipkind HS.

Matern Child Health J. 2014 May;18(4):829-38. doi: 10.1007/s10995-013-1307-9.

18.

Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn.

Huybrechts KF, Bateman BT, Palmsten K, Desai RJ, Patorno E, Gopalakrishnan C, Levin R, Mogun H, Hernandez-Diaz S.

JAMA. 2015 Jun 2;313(21):2142-51. doi: 10.1001/jama.2015.5605.

19.

Maternal complications and perinatal outcomes associated with gestational hypertension and severe preeclampsia in Taiwanese women.

Liu CM, Cheng PJ, Chang SD.

J Formos Med Assoc. 2008 Feb;107(2):129-38. doi: 10.1016/S0929-6646(08)60126-6.

20.

Safety of selective serotonin reuptake inhibitors in pregnancy.

Alwan S, Friedman JM.

CNS Drugs. 2009;23(6):493-509. doi: 10.2165/00023210-200923060-00004. Review.

PMID:
19480468
Items per page

Supplemental Content

Support Center